Make Sure You’re Applying Massive Prostate Biopsy, Urethral Dilation Bundlings

Modifier 59 sometimes will rescue your reimbursement.

Just when you’re finally getting a handle on all the 2010 coding changes, here comes round two of the Correct Coding Initiative (CCI) edits. Version 16.1, which took effect April 1, will tie your hands when coding many common urology procedures, including prostate biopsies and urethral dilations.

Heads up: CCI 16.1 includes 2,054 new active pairs and 1,947 modifier changes, says Frank D. Cohen, MPA, MBB, senior analyst with MIT Solutions Inc. in Clearwater, Fla.

“For urology, there will be 78 edit pair additions and two edit pair deletions,” says Michael A. Ferragamo, MD, FACS, clinical assistant professor of urology at the State University of New York at Stony Brook.To ensure you get paid appropriately for your urologist’s services this quarter, here’s the rundown of the most important changes.

Say Goodbye to Biopsy with Several Prostate Procedures

You can no longer report prostate biopsy codes 55700 (Biopsy, prostate; needle or punch, single or multiple, any approach) or 55706 (Biopsies, prostate, needle, transperineal, stereotactic template guided saturation sampling, including imaging guidance) with 52630 (Transurethral resection; residual or re-growth of obstructive prostate tissue including control of postoperative bleeding, complete [vasectomy, meatotomy, cystourethroscopy, urethral calibration and/or dilation, and internal urethrotomy are included]). Your payer will reimburse you for 52630 but deny the biopsy codes, and you cannot use a modifier to separate these new edits.

“I have a major issue with the bundling of 55700 and 52630,” laments Alice Kater, CPC, PCS, coder for Urology Associates of South Bend, Ind. Kater says her urologists perform a good number of prostate biopsies transrectally and 55700 is what she uses because the descriptor says “any approach.” When you are performing two separate procedures utilizing two different approaches, how can they be bundled?”

Silver lining: CCI also bundles 55705 (Biopsy, prostate; incisional, any approach) into 52630, but the edit carries a “1” modifier indicator. Therefore, you can break that bundle if clinical circumstances warrant separate reporting.

Additionally: As of April 1, transurethral resection of the prostate (TURP) code 52601 (Transurethral electrosurgical resection of prostate, including control of postoperative bleeding, complete [vasectomy, meatotomy, cystourethroscopy, urethral calibration and/or dilation, and internal urethrotomy are included]) and laser prostatectomy codes (52647-52649) are mutually exclusive with saturation biopsy of the prostate under anesthesia (55706).

The 52601/55706 and 52648/55706 bundles have a modifier indicator of “0” so you can never bill those codes together. On the other hand, the 52647/55706 and 52649/55706 bundles both have a modifier indicator of “1,” which means you can report the codes together underspecific clinical circumstances using a modifier such as modifier 59 (Distinct procedural service), Ferragamo says.

You will also find prostate biopsy listed as a column 2 code (55706), forming mutually exclusive edits with the following column 1 codes:

  • Transurethral destruction of prostate tissue (53850-53852)
  • Prostatectomy (55801-55845, 55866)
  • Cryosurgical ablation of the prostate (55873).

The modifier indicator for all of these above edits is “1.” You can break the bundles when clinical circumstances warrant.

Beware Multiple Urethral Dilation Edits

CCI 16.1 hits urethral dilation coding hard. To find out what edits you need to apply to your urology practice pronto, subscribe to the Urology Coding Alert.

Editor: Leesa A. Isreal, CPC, CUC, CMBS

Sign up for the upcoming live audio conference, Modifier 59 and NCCI Edits, or order the CD/transcripts.

Be a hero. Sign up for Supercoder.com, and join the coding community at the Supercoder.com Facebook Fan Page.

Share:

More Posts

ICD-10 Data: Does It Matter?

It is often argued that ICD-10 coding does nothing for the patient. Recently that point was made at the U.S. House Energy & Commerce Subcommittee on Health hearing “Examining ICD-10 Implementation” last week.

Read More »